Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

413 studies match

clinicaltrialsPublishedShowing 101–150 of 413 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02954874	Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer	active not recruiting	Phase 3	1,195	National Cancer Institute (NCI)NIH	3	Aug 31, 2026	clinicaltrials
NCT03793166	Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study	active not recruiting	Phase 3	1,175	National Cancer Institute (NCI)NIH	2	Aug 31, 2026